BACKGROUND: Previous studies have suggested that a variant in the melanocortin-4 receptor (MC4R) gene is important in protecting against common obesity. Larger studies are needed, however, to confirm this relation. METHODS: We assessed the association between the V103I polymorphism in the MC4R gene and obesity in three UK population based cohort studies, totalling 8304 individuals. We also did a meta-analysis of relevant studies, involving 10 975 cases and 18 588 controls, to place our findings in context. FINDING: In an analysis of all studies, individuals carrying the isoleucine allele had an 18% (95% confidence interval 4-30%, P=0.015) lower risk of obesity compared with non-carriers. There was no heterogeneity among studies and no apparent publication bias. INTERPRETATION: This study confirms that the V103I polymorphism protects against human obesity at a population level. As such it provides proof of principle that specific gene variants may, at least in part, explain susceptibility and resistance to common forms of human obesity. A better understanding of the mechanisms underlying this association will help determine whether changes in MC4R activity have therapeutic potential.
BACKGROUND: Previous studies have suggested that a variant in the melanocortin-4 receptor (MC4R) gene is important in protecting against common obesity. Larger studies are needed, however, to confirm this relation. METHODS: We assessed the association between the V103I polymorphism in the MC4R gene and obesity in three UK population based cohort studies, totalling 8304 individuals. We also did a meta-analysis of relevant studies, involving 10 975 cases and 18 588 controls, to place our findings in context. FINDING: In an analysis of all studies, individuals carrying the isoleucine allele had an 18% (95% confidence interval 4-30%, P=0.015) lower risk of obesity compared with non-carriers. There was no heterogeneity among studies and no apparent publication bias. INTERPRETATION: This study confirms that the V103I polymorphism protects against human obesity at a population level. As such it provides proof of principle that specific gene variants may, at least in part, explain susceptibility and resistance to common forms of human obesity. A better understanding of the mechanisms underlying this association will help determine whether changes in MC4R activity have therapeutic potential.
Authors: I M Heid; C Vollmert; A Hinney; A Döring; F Geller; H Löwel; H-E Wichmann; T Illig; J Hebebrand; F Kronenberg Journal: J Med Genet Date: 2005-04 Impact factor: 6.318
Authors: A Hinney; A Schmidt; K Nottebom; O Heibült; I Becker; A Ziegler; G Gerber; M Sina; T Görg; H Mayer; W Siegfried; M Fichter; H Remschmidt; J Hebebrand Journal: J Clin Endocrinol Metab Date: 1999-04 Impact factor: 5.958
Authors: W Gu; Z Tu; P W Kleyn; A Kissebah; L Duprat; J Lee; W Chin; S Maruti; N Deng; S L Fisher; L S Franco; P Burn; K A Yagaloff; J Nathan; S Heymsfield; J Albu; F X Pi-Sunyer; D B Allison Journal: Diabetes Date: 1999-03 Impact factor: 9.461
Authors: D R Williams; N J Wareham; D C Brown; C D Byrne; P M Clark; B D Cox; L J Cox; N E Day; C N Hales; C R Palmer Journal: Diabet Med Date: 1995-01 Impact factor: 4.359
Authors: Tao Huang; Yan Zheng; Adela Hruby; Donald A Williamson; George A Bray; Yiru Shen; Frank M Sacks; Lu Qi Journal: J Nutr Date: 2017-02-01 Impact factor: 4.798
Authors: George Stratigopoulos; Charles A LeDuc; Naoki Matsuoka; Roee Gutman; Richard Rausch; Scott A Robertson; Martin G Myers; Wendy K Chung; Streamson C Chua; Rudolph L Leibel Journal: Obesity (Silver Spring) Date: 2008-11-06 Impact factor: 5.002
Authors: André Scherag; Christian Dina; Anke Hinney; Vincent Vatin; Susann Scherag; Carla I G Vogel; Timo D Müller; Harald Grallert; H-Erich Wichmann; Beverley Balkau; Barbara Heude; Marjo-Riitta Jarvelin; Anna-Liisa Hartikainen; Claire Levy-Marchal; Jacques Weill; Jérôme Delplanque; Antje Körner; Wieland Kiess; Peter Kovacs; Nigel W Rayner; Inga Prokopenko; Mark I McCarthy; Helmut Schäfer; Ivonne Jarick; Heiner Boeing; Eva Fisher; Thomas Reinehr; Joachim Heinrich; Peter Rzehak; Dietrich Berdel; Michael Borte; Heike Biebermann; Heiko Krude; Dieter Rosskopf; Christian Rimmbach; Winfried Rief; Tobias Fromme; Martin Klingenspor; Annette Schürmann; Nadja Schulz; Markus M Nöthen; Thomas W Mühleisen; Raimund Erbel; Karl-Heinz Jöckel; Susanne Moebus; Tanja Boes; Thomas Illig; Philippe Froguel; Johannes Hebebrand; David Meyre Journal: PLoS Genet Date: 2010-04-22 Impact factor: 5.917